Contact this trialFirst, we need to learn more about you.
Scalp Cooling for Breast Cancer
Recruiting1 awardPhase 2
Boston, Massachusetts
This trial is being conducted to compare rates of hair loss in people with metastatic breast cancer who use the Paxman Scalp Cooling System during their standard of care treatment with either sacituzumab govitecan, trastuzumab deruxtecan, or eribulin, versus those who do not use scalp cooling.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.